Study / S3UOSEGB02022-11-23

Massively parallel reporter assays and variant scoring identified functional variants and target genes for melanoma loci and highlighted cell-type specificity

Erping Long, Jinhu Yin, Karen M. Funderburk, Mai Xu, James Feng et al.

About this study

The most recent genome-wide association study (GWAS) of cutaneous melanoma identified 54 risk-associated loci, but functional variants and their target genes for most have not been established. Here, we performed massively parallel reporter assays (MPRAs) by using malignant melanoma and normal melanocyte cells and further integrated multi-layer annotation to systematically prioritize functional variants and susceptibility genes from these GWAS loci. Of 1,992 risk-associated variants tested in MPRAs, we identified 285 from 42 loci (78% of the known loci) displaying significant allelic transcriptional activities in either cell type (FDR < 1%). We further characterized MPRA-significant variants by motif prediction, epigenomic annotation, and statistical/functional fine-mapping to create integrative variant scores, which prioritized one to six plausible candidate variants per locus for the 42 loci and nominated a single variant for 43% of these loci. Overlaying the MPRA-significant variants with genome-wide significant expression or methylation quantitative trait loci (eQTLs or meQTLs, respectively) from melanocytes or melanomas identified candidate susceptibility genes for 60% of variants (172 of 285 variants). CRISPRi of top-scoring variants validated their cis-regulatory effect on the eQTL target genes, MAFF (22q13.1) and GPRC5A (12p13.1). Finally, we identified 36 melanoma-specific and 45 melanocyte-specific MPRA-significant variants, a subset of which are linked to cell-type-specific target genes. Analyses of transcription factor availability in MPRA datasets and variant-transcription factor interaction in eQTL datasets highlighted the roles of transcription factors in cell-type-specific variant functionality. In conclusion, MPRAs along with variant scoring effectively prioritized plausible candidates for most melanoma GWAS loci and highlighted cellular contexts where the susceptibility variants are functional.

Full author list & citation

Erping Long, Jinhu Yin, Karen M. Funderburk, Mai Xu, James Feng, Alexander Kane, Tongwu Zhang, Timothy Myers, Alyxandra Golden, Rohit Thakur, Hyunkyung Kong, Lea Jessop, Eun Young Kim, Kristine Jones, Raj Chari, Mitchell J. Machiela, Kai Yu, Melanoma Meta-Analysis Consortium, Mark M. Iles, Maria Teresa Landi, Matthew H. Law, Stephen J. Chanock, Kevin M. Brown, Jiyeon Choi. Massively parallel reporter assays and variant scoring identified functional variants and target genes for melanoma loci and highlighted cell-type specificity. 2022-11-23. https://doi.org/10.1016/j.ajhg.2022.11.006

Experiments 2

E2EY1H87R

UACC903 melanoma-cell episomal allelic MPRA

The 191,232-oligo library tested 1,992 melanoma-GWAS variants as 145-bp reference and alternative sequences in both orientations with barcode tags. The library was transfected into UACC903 human melanoma cells in 8 biological transfections, normalized to MPRA DNA Inputs 1 or 2.

Episomal Plasmid MPRAHumanhg19
Explore data
E4RO0XIMK

C283T immortalized melanocyte episomal allelic MPRA

The 191,232-oligo library tested 1,992 melanoma-GWAS variants as 145-bp reference and alternative sequences in both orientations with barcode tags. The library was transfected into the C283T human immortalized melanocyte line in 5 biological transfections, normalized to MPRA DNA Inputs 2 or 3.

Episomal Plasmid MPRAHumanhg19
Explore data

Raw source data 19 files

Original supplemental and deposited inputs retained for this study. Download files individually or together as a ZIP; nested folders are preserved. Source reuse terms apply, and sequencing reads may be omitted.

Download all 19 files (ZIP)GSE210356_family.soft.gzGSE210356_filelist.txtGSM6428903_Melanoma_MPRA_T1_count_TPM.txt.gzGSM6428904_Melanoma_MPRA_T2_count_TPM.txt.gzGSM6428905_Melanoma_MPRA_T3_count_TPM.txt.gzGSM6428906_Melanoma_MPRA_T4_count_TPM.txt.gzGSM6428907_Melanoma_MPRA_T5_count_TPM.txt.gzGSM6428908_Melanoma_MPRA_T6_count_TPM.txt.gzGSM6428909_Melanoma_MPRA_T7_count_TPM.txt.gzGSM6428910_Melanoma_MPRA_T8_count_TPM.txt.gzGSM6428911_Melanocyte_MPRA_T1_count_TPM.txt.gzGSM6428912_Melanocyte_MPRA_T2_count_TPM.txt.gzGSM6428913_Melanocyte_MPRA_T3_count_TPM.txt.gzGSM6428914_Melanocyte_MPRA_T4_count_TPM.txt.gzGSM6428915_Melanocyte_MPRA_T5_count_TPM.txt.gzGSM6428916_MPRA_Input_1_count_TPM.txt.gzGSM6428917_MPRA_Input_2_count_TPM.txt.gzGSM6428918_MPRA_Input_3_count_TPM.txt.gzsupplementary_tables_S1-S19.xlsx

Cite OpenMPRA

Cite the OpenMPRA database. Include your access date because the collection changes over time.

Please also cite the source studies when using their data.